Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026)
Retractable Technologies (RVP) posted Net Income towards Common Stockholders of -$4.3 million for Q1 2026, down 78.03% on a QoQ basis from -$2.4 million in Q4 2025, and up 59.44% year-over-year from -$2.7 million in Q1 2025.
Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Retractable Technologies' Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 59.44% year-over-year to -$4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.5 million (up 71.71% YoY) and the FY2025 annual result came in at -$12.8 million, down 5.6% from the prior year.
- Net Income towards Common Stockholders was -$4.3 million for Q1 2026 at Retractable Technologies, down from -$2.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $7.6 million in Q1 2022 and bottomed at -$14.2 million in Q2 2024.
- A 5-year average of -$1.9 million and a median of -$2.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 2944.05% — and 2025, when it plunged 2939.99%.
- Retractable Technologies' Net Income towards Common Stockholders stood at -$4.3 million in 2022, then soared by 96.99% to -$130557.0 in 2023, then soared by 2944.05% to $3.7 million in 2024, then plunged by 164.79% to -$2.4 million in 2025, then slumped by 78.03% to -$4.3 million in 2026.
- Business Quant data shows RVP's Net Income towards Common Stockholders at -$4.3 million in Q1 2026, -$2.4 million in Q4 2025, and $313436.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Retractable Technologies | 20.49 Mn | -15.13 Mn | -838,408.00 | -4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.28 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | 313,436.00 |
| Jun 30, 2025 | -145,082.00 |
| Mar 31, 2025 | -10.56 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -14.22 Mn |
| Mar 31, 2024 | 371,773.00 |
| Dec 31, 2023 | -130,557.00 |
| Sep 30, 2023 | -4.12 Mn |
| Jun 30, 2023 | -3.93 Mn |
| Mar 31, 2023 | 932,861.00 |
| Dec 31, 2022 | -4.34 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | -3.70 Mn |
| Mar 31, 2022 | 7.56 Mn |
| Dec 31, 2021 | 20.87 Mn |
| Sep 30, 2021 | 6.46 Mn |
| Jun 30, 2021 | 10.60 Mn |